首页> 美国卫生研究院文献>other >MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation Migration and Invasion and Promotes Apoptosis
【2h】

MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation Migration and Invasion and Promotes Apoptosis

机译:MiR-133b在人类骨肉瘤中被下调并抑制骨肉瘤细胞的增殖迁移和侵袭并促进细胞凋亡。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) decrease the expression of specific target oncogenes or tumor suppressor genes and thereby play crucial roles in tumorigenesis and tumor growth. To date, the potential miRNAs regulating osteosarcoma growth and progression are not fully identified yet. In this study, the miRNA microarray assay and hierarchical clustering analysis were performed in human osteosarcoma samples. In comparison with normal human skeletal muscle, 43 miRNAs were significantly differentially expressed in human osteosarcomas (fold change ≥2 and p≤0.05). Among these miRNAs, miR-133a and miR-133b expression was decreased by 135 folds and 47 folds respectively and the decreased expression was confirmed in both frozen and paraffin-embedded osteosarcoma samples. The miR-133b precursor expression vector was then transfected into osteosarcoma cell lines U2-OS and MG-63, and the stable transfectants were selected by puromycin. We found that stable over-expression of miR-133b in osteosarcoma cell lines U2-OS and MG-63 inhibited cell proliferation, invasion and migration, and induced apoptosis. Further, over-expression of miR-133b decreased the expression of predicted target genes BCL2L2, MCL-1, IGF1R and MET, as well as the expression of phospho-Akt and FAK. This study provides a new insight into miRNAs dysregulation in osteosarcoma, and indicates that miR-133b may play as a tumor suppressor gene in osteosarcoma.
机译:微小RNA(miRNA)会降低特定靶癌基因或抑癌基因的表达,从而在肿瘤发生和肿瘤生长中发挥关键作用。迄今为止,尚未完全鉴定出调节骨肉瘤生长和进展的潜在miRNA。在这项研究中,在人骨肉瘤样品中进行了miRNA芯片测定和层次聚类分析。与正常人骨骼肌相比,在人骨肉瘤中有43个miRNA显着差异表达(倍数≥2和p≤0.05)。在这些miRNA中,miR-133a和miR-133b的表达分别降低了135倍和47倍,并且在冷冻和石蜡包埋的骨肉瘤样品中均证实了表达降低。然后将miR-133b前体表达载体转染到骨肉瘤细胞系U2-OS和MG-63中,并用嘌呤霉素选择稳定的转染子。我们发现,miR-133b在骨肉瘤细胞U2-OS和MG-63中的稳定过度表达抑制细胞增殖,侵袭和迁移,并诱导细胞凋亡。此外,miR-133b的过表达降低了预测目标基因BCL2L2,MCL-1,IGF1R和MET的表达,以及磷酸化Akt和FAK的表达。这项研究提供了对骨肉瘤中miRNA失调的新见解,并表明miR-133b可能在骨肉瘤中起着抑癌基因的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号